TrademarkDir
CROSS-FUSE
LIVE

Serial Number

77284786

Owner

XTANT MEDICAL HOLDINGS, INC.

Attorney

Jeanette E. Sinclare

Filing Date

Sep 20, 2007

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CROSS-FUSE Trademark

Serial Number: 77284786 • Registration: 3544634

CROSS-FUSE is a trademark filed by XTANT MEDICAL HOLDINGS, INC. on September 20, 2007. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

XTANT MEDICAL HOLDINGS, INC. (84 trademarks)

664 Cruiser Lane
Belgrade, MT 59714

Entity Type: 03

PIONEER SURGICAL TECHNOLOGY, INC. (56 trademarks)

375 RIVER PARK CIRCLE
MARQUETTE, MI 49855

Entity Type: 03

Trademark Details

Filing Date

September 20, 2007

Registration Date

December 9, 2008

Published for Opposition

June 24, 2008

Goods & Services

Spinal implants comprising artificial material; spinal fixation devices; surgical instruments for use in orthopedic and spinal surgery

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 6, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 6, 2024 COAR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 31, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 10, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 25, 2023 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 4, 2023 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 11, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 11, 2022 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 17, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 17, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 17, 2018 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 17, 2018 APRE
TEAS SECTION 8 & 9 RECEIVED
Dec 3, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 9, 2017 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 28, 2014 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 28, 2014 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 28, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
May 6, 2014 815F
TEAS SECTION 8 & 15 RECEIVED
May 6, 2014 E815
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2008 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 5, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 4, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 3, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 3, 2008 AITU
USE AMENDMENT FILED
Oct 1, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 1, 2008 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2008 NOAM
PUBLISHED FOR OPPOSITION
Jun 24, 2008 PUBO
NOTICE OF PUBLICATION
Jun 4, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 21, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
May 5, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2008 CRFA
ASSIGNED TO LIE
May 5, 2008 ALIE
PAPER RECEIVED
May 2, 2008 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2007 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2007 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2007 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2007 DOCK
NEW APPLICATION ENTERED
Sep 25, 2007 NWAP

Related Trademarks

More from this Owner

FACTORBOND TECHNOLOGY

FACTORBOND TECHNOLOGY

NANOSS STRATA WITH VANTAGE TECHNOLOGY

NANOSS STRATA WITH VANTAGE TECHNOLOGY

NANOSS STRATA WITH VANTAGE TECHNOLOGY

NANOSS STRATA WITH VANTAGE TECHNOLOGY

HELEXIS

HELEXIS

HELEXIS

HELEXIS

OSTEOFACTOR PRO

OSTEOFACTOR PRO